156 results on '"Wang, Xuya"'
Search Results
2. GPR65 contributes to constructing immunosuppressive microenvironment in glioma
3. TCAF2 drives glioma cellular migratory/invasion properties through STAT3 signaling
4. Tar inhibition for hydrogen production from biomass gasification assisted by machine learning
5. Energy-efficient design of cyclone separators: Machine learning prediction of particle self-rotation velocities
6. Can local government implicit debt raise regional financial market spillover? Evidence from China
7. Correction: TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas
8. Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial
9. Cross-regional connectedness of financial market: Measurement and determinants
10. Research on Progress and Trend of Display Space Interaction Design Based on Bibliometrics
11. PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma
12. LINE-1 expression in cancer correlates with p53 mutation, copy number alteration, and S phase checkpoint
13. The Application of Artificial Intelligence in AI News Anchor
14. TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas
15. HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion
16. The Application of Artificial Intelligence in AI News Anchor
17. Immune Checkpoint Blockade Outcome in Small-Cell Lung Cancer and Its Relationship With Retinoblastoma Mutation Status and Function
18. Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial
19. Transcription factor profiling reveals molecular choreography and key regulators of human retrotransposon expression
20. “Perfect” designer chromosome V and behavior of a ring derivative
21. Bug mapping and fitness testing of chemically synthesized chromosome X
22. Synthesis, debugging, and effects of synthetic chromosome consolidation : synVI and beyond
23. TMIC-14. CLEC5A REGULATES TAM POLARIZATION, TME IMMUNOSUPPRESSION AND DISEASE PROGRESSION IN GLIOBLASTOMA
24. An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer
25. LINE-1 ORF2p expression is nearly imperceptible in human cancers
26. Supplementary File 5 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers
27. Supplementary File 1 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers
28. Supplementary File 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers
29. Extended Methods from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers
30. Supplementary File 3 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers
31. Supplementary Figures from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers
32. Supplementary tables 1 and 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers
33. Data from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers
34. Supplementary File 4 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers
35. Regulation of CTR2 mRNA by the nonsense-mediated mRNA decay pathway
36. China Artificial Intelligence Industry Insights
37. PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma
38. TMIC-21. THE ROLE OF CLEC5A ON M2-LIKE TUMOR-ASSOCIATED MACROPHAGES POLARIZATION AND DISEASE PROGRESSION IN GLIOBLASTOMA
39. Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial
40. Abstract CT023: Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 biomarker analyses
41. A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma
42. Correction: Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
43. S100A11 is a potential prognostic biomarker and correlated with tumor immunosuppressive microenvironment in glioma.
44. Overcoming T-cell exhaustion in glioblastoma: A narrative review
45. Comprehensive Scanning Mutagenesis of Human Retrotransposon LINE-1 Identifies Motifs Essential for Function
46. Modeling transcriptional profiles of gene perturbation with deep neural network
47. CheckMate 9KD cohort A1 final analysis: Nivolumab (NIVO) + rucaparib for post-chemotherapy (CT) metastatic castration-resistant prostate cancer (mCRPC).
48. Complementary detection of genomic alterations in metastatic castration-resistant prostate cancer (mCRPC) from CheckMate 9KD through analyses of tumor tissue and plasma DNA.
49. Abstract 2117: Immune contexture of breast cancer subtypes in real-world molecular data
50. Abstract 2047: Association of retinoblastoma function with response to immuno-oncology treatment in patients with small cell lung cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.